The incidence (excluding Covid-19) is 190,000 per annum getting ARDS. Killing 74,500.
https://www.medscape.com/answers/165139-43269/what-is-the-incidence-of-acute-respiratory-distress-syndrome-ards-in-the-us
Adding to this...
"effective pharmacological therapies for ARDS have not yet been identified."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709677/
So the silver lining is HUGE regardless, enabling Mesoblast to essentially fix a major killer.
IMO Trump will open too early, we will get a re-surgence and it will be back to square one, or if Mesoblast has a fix which we do, then he will re-open with the backup saying 'we have a cure' so no need to worry about getting Covid and dying from it (well the majority anyway, but Trump will spin it in the best way possible and it will save his hide and possibly get him re-elected).
Revenue... 190,000 x $70,000 USD (I think that was the number) = $13.3 billion USD per annum.
One word.. WOW.
You think it will only be used in the USA. HA! The whole developed world (who can afford it) will be begging to partner and approve it in their respective countries.
Trial in Australia - Silviu on TV, page-65
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |